Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenetix 350 comparative assessment of image quality for coronary CT angiography
2010-021826-37Phase 4Completed
- Sponsor
- Guerbet
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of iobitridol in coronary arteriosclerosis (3 arms), sponsored by Guerbet. Primary endpoint: Evaluability of CT scans. Started Aug 2010; status: completed.
02
Drugs
iobitridol
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2010-021826-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021826-37.